Bangladesh’s pharmaceutical companies risk losing the chance to produce at least 15 costly biologic drugs royalty-free, as ...

Jicheng Yang of Wanhuida Intellectual Property considers whether a notable Beijing Intellectual Property Court decision ...

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.

Biosimilar drugs are drugs that are a lot like biologics, but maybe not identical. Learn why this matters inside.

A key patent for Merck’s blockbuster drug Keytruda will expire in 2028. The cancer therapy brought the company $29.5 billion last year.

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

The life expectancy has increased in the U.S. and worldwide, contributing to healthcare companies retaining their patients ...

Through validations and process across Europe these patents were granted and cover the majority of the Euoprean population. In total over 20 countries in Europe have patent coverage for QN-302.

Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance ...